Janus Henderson Group
SRPT icon

Janus Henderson Group’s Sarepta Therapeutics SRPT Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$665K Sell
38,877
-3,325,968
-99% -$56.9M ﹤0.01% 1805
2025
Q1
$237M Sell
3,364,845
-963,478
-22% -$67.8M 0.13% 172
2024
Q4
$526M Sell
4,328,323
-30,188
-0.7% -$3.67M 0.27% 88
2024
Q3
$544M Buy
4,358,511
+543,143
+14% +$67.8M 0.28% 86
2024
Q2
$603M Sell
3,815,368
-1,076,049
-22% -$170M 0.32% 70
2024
Q1
$633M Sell
4,891,417
-454,368
-8% -$58.8M 0.35% 63
2023
Q4
$515M Sell
5,345,785
-436,664
-8% -$42.1M 0.31% 79
2023
Q3
$701M Buy
5,782,449
+334,782
+6% +$40.6M 0.46% 44
2023
Q2
$624M Buy
5,447,667
+539,463
+11% +$61.8M 0.39% 60
2023
Q1
$677M Sell
4,908,204
-1,119,812
-19% -$154M 0.45% 47
2022
Q4
$781M Sell
6,028,016
-6,927,962
-53% -$898M 0.56% 35
2022
Q3
$1.43B Buy
12,955,978
+5,723,306
+79% +$633M 0.54% 35
2022
Q2
$542M Sell
7,232,672
-225,910
-3% -$16.9M 0.37% 62
2022
Q1
$583M Buy
7,458,582
+212,720
+3% +$16.6M 0.28% 80
2021
Q4
$652M Sell
7,245,862
-152,736
-2% -$13.8M 0.27% 83
2021
Q3
$684M Buy
7,398,598
+503,833
+7% +$46.6M 0.3% 75
2021
Q2
$536M Buy
6,894,765
+722,902
+12% +$56.2M 0.23% 108
2021
Q1
$460M Buy
6,171,863
+2,296,187
+59% +$171M 0.21% 116
2020
Q4
$661M Sell
3,875,676
-74,876
-2% -$12.8M 0.31% 75
2020
Q3
$555M Buy
3,950,552
+332,723
+9% +$46.7M 0.29% 76
2020
Q2
$580M Buy
3,617,829
+93,846
+3% +$15M 0.33% 65
2020
Q1
$345M Buy
3,523,983
+353,301
+11% +$34.6M 0.24% 99
2019
Q4
$409M Buy
3,170,682
+865,342
+38% +$112M 0.21% 109
2019
Q3
$174M Sell
2,305,340
-422,742
-15% -$31.8M 0.09% 229
2019
Q2
$415M Buy
2,728,082
+62,039
+2% +$9.43M 0.22% 106
2019
Q1
$318M Buy
2,666,043
+826,449
+45% +$98.5M 0.18% 142
2018
Q4
$201M Buy
1,839,594
+1,431,172
+350% +$156M 0.13% 202
2018
Q3
$66M Buy
408,422
+406,022
+16,918% +$65.6M 0.04% 513
2018
Q2
$317K Buy
+2,400
New +$317K ﹤0.01% 1328
2016
Q4
Sell
-35,000
Closed -$2.15M 861
2016
Q3
$2.15M Buy
+35,000
New +$2.15M 0.02% 465